Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Straumann Holding AG is a Swiss-based global leader in tooth replacement and orthodontic solutions, specializing in the research, development, manufacture, and supply of advanced dental products. Its comprehensive portfolio includes dental implants and components made from titanium, titanium alloy, and ceramics; prosthetic elements from ceramics, metal, or polymer; clear aligners; biomaterials for tissue generation; and digital solutions such as CADCAM prosthetics, scanners, milling machines, 3D printers, and software licenses. The company serves general dentists, specialists, dental technicians, and laboratories through an extensive network of subsidiaries and partners in over 100 countries. Originally focused on premium implants, Straumann expanded into value segments via acquisitions like Neodent in 2012, Anthogyr, and ClearCorrect, holding significant market shares in both premium (nearly half globally) and value markets. Headquartered in Basel since 1954, with over 10,400 employees worldwide, Straumann Holding AG drives innovation in restorative, orthodontic, and preventative dentistry, partnering with clinics, institutes, and universities to advance oral care technologies.
Margins and capital returns are both well above average: 21.08% operating margin, ROIC at 17.14%. Consistent with durable pricing power, though that alone doesn't make it a buy.
Revenue grew 4.1%, steady but not accelerating. Margins contracted 2.9pp, which offsets some of the top-line progress.
Free cash flow declined 11% versus the prior year, cash generation momentum has weakened. ROIC dropped from 20.96% to 17.14%, capital efficiency is deteriorating.
Profitability & Returns
Revenue (TTM)
CHF 2.61B
▲ +4.1% YoY
Net Income (TTM)
CHF 357M
▼ -8.4% YoY
Op. Margin
21.08%
▼ -2.9pp YoY
ROIC
17.14%
▼ -3.8pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
CHF 281M
▼ -11.1% YoY
Op. Cash Flow (TTM)
CHF 456M
▲ +5.1% YoY
Net Debt
-CHF 71M
Net Cash Position
Cash & Equiv.
CHF 490M
3Y CAGR: +3.9%
3Y CAGR: +8.5%
Continue Research